Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities

Vaccine

Volumn 23, Issue 4, 2004, Pages 435-443

  Sastre, Patricia ^a   Melero, José A ^a   García Barreno, Blanca ^a   Palomo, Concepción ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Flebogamma; Human immunoglobulins; Human respiratory syncytial virus

Indexed keywords

IMMUNOGLOBULIN; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIRUS NEUTRALIZATION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; NEUTRALIZATION TESTS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS;

EID: 7744241823     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.023     Document Type: Article

References (40)

1. F.W. Henderson, A.M. Collier, W.A. Clyde Jr., and F.W. Denny Respiratory-syncytial-virus infections, reinfections and immunity: a prospective, longitudinal study in young children N. Engl. J. Med. 300 1979 530 534
2. A.R. Falsey, R.M. McCann, W.J. Hall, M.A. Tanner, M.M. Criddle, and M.A. Formica Acute respiratory tract infection in daycare centers for older persons J. Am. Geriatr. Soc. 43 1995 30 36
3. J.A. Englund, L.J. Anderson, and F.S. Rhame Nosocomial transmission of respiratory syncytial virus in immunocompromised adults J. Clin. Microbiol. 29 1991 115 119
4. L.J. Anderson, J.C. Heirholzer, C. Tson, R.M. Hendry, B.N. Fernie, and Y. Stone Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies J. Infect. Dis. 151 1985 626 633
5. M.A. Mufson, C. Örvell, B. Rafnar, and E. Norrby Two distinct subtypes of human respiratory syncytial virus J. Gen. Virol. 66 1985 2111 2114
6. P.L. Collins, R.M. Chanock, and B.R. Murphy Respiratory syncytial virus D.M. Knipe P.M. Howley Fields virology 2001 Lippincott Williams and Wilkins Philadelphia 1443 1485
7. S. Levine, R. Klaiber-Franco, and P.R. Paradiso Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus J. Gen. Virol. 68 1987 2521 2524
8. E.E. Walsh, and J. Hruska Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein J. Virol. 47 1983 171 177
9. E.E. Walsh, C.B. Hall, M. Briselli, M.W. Brandiss, and J.J. Schlesinger Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection J. Infect. Dis. 155 1987 1198 1204
10. M. Connors, P.L. Collins, C.Y. Firestone, and B.R. Murphy Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived J. Virol. 65 1991 1634 1637
11. P.J. Watt, B.S. Robinson, C.R. Pringle, and DA.J. Tyrrell Determinants of susceptibility to challenge and the antibody response of adults volunteers given experimental respiratory syncytial virus vaccines Vaccine 8 1990 231 236
12. C.B. Hall, C.B. Walsh, C.E. Long, and K.C. Schnabel Immunity to and frequency of reinfection with respiratory syncytial virus J. Infect. Dis. 163 1991 693 698
13. W.P. Glezen, L.H. Taber, A. Frank, and J. Kasel Risk of primary infection and reinfection with respiratory syncytial virus Am. J. Dis. Child 140 1986 543 546
14. A.R. Falsey, and E.E. Walsh Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults J. Infect. Dis. 177 1998 463 466
15. W.H. Alwan, and P.J. Openshaw Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins Vaccine 11 1993 431 437
16. J.R. Groothuis, E. Simoes, M.J. Levin, C.B. Hall, C.E. Long, and W.J. Rodriguez Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children N. Engl. J. Med. 329 1993 1524 1530
17. G.R. Siber, D. Leombruno, V. Leszczynski, J. McIver, D. Bodkin, and R. Gonin Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin J. Infect. Dis. 169 1994 1368 1373
18. The Impact-Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 102 1998 531 537
19. J.A. López, R. Bustos, C. Örvell, M. Berois, J. Arbiza, and B. García-Barreno Antigenic structure of human respiratory syncytial virus fusion glycoprotein J. Virol. 72 1998 6922 6928
20. I. Martínez, and J.A. Melero Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein J. Gen. Virol. 79 1998 2215 2220
21. B. García-Barreno, J.L. Jorcano, T. Aukenbauer, C. López-Galíndez, and J.A. Melero Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV) Virus Res. 9 1988 307 322
22. G.P. Bembridge, R. García-Beato, J.A. López, J.A. Melero, and G. Taylor Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment protein J. Immunol. 161 1998 2473 2480
23. G.P. Bembridge, J.A. López, R. Bustos, J.A. Melero, R. Cook, and H. Mason Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge J. Virol. 73 1999 10086 10094
24. M.B. Ruiz-Argüello, L. González-Reyes, L.J. Calder, C. Palomo, D. Martin, and M.J. Sanz Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment Virology 298 2002 317 326
25. Escribano-Romero, Rawling J, García-Barreno B, Melero JA. The soluble form of human respiratory syncytial virus attachment protein differs from the membrane bound form in its oligomeric sate but is still capable of binding to cell surface proteoglycans. J Virol, in press.
26. B. García-Barreno, C. Palomo, C. Peñas, T. Delgado, P. Perez-Breña, and J.A. Melero Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins J. Virol. 63 1989 925 932
27. I. Martínez, J. Dopazo, and J.A. Melero Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants J. Gen. Virol. 78 1997 2419 2429
28. J. Cristina, J.A. López, C. Albo, B. García-Barreno, J. García, and J.A. Melero Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity Virology 174 1990 126 134
29. P.A. Cane, H.M. Thomas, A.F. Simpson, J.E. Evans, C.A. Hart, and C.R. Pringle Analysis of the human serological immune response to a variable region of the attachment (G) protein of human respiratory syncytial virus during primary infection J. Med. Virol. 48 1996 253 261
30. C. Palomo, P.A. Cane, and J.A. Melero Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains J. Med. Virol. 60 2000 468 474
31. A.R. Falsey, E.E. Walsh, R.J. Looney, J.E. Kolassa, M.A. Formica, and M.C. Criddle Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults J. Med. Virol. 59 1999 221 226
32. S.R. Chala, B. García-Barreno, J.A. Melero, and C. Palomo Prevalence of anti-human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population J. Med. Virol. 71 2003 298 304
33. X. Zhao, M. Singh, V.N. Malashkevich, and P.S. Kim Structural characterization of the human respiratory syncytial virus fusion protein core Proc. Natl. Acad. Sci. U.S.A. 97 2000 14172 14177
34. J. Arbiza, G. Taylor, J.A. López, J. Furze, S. Wyld, and P. Whyte Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus J. Gen. Virol. 73 1992 225 234
35. G.E. Scopes, P.J. Watt, and P.R. Lambden Identification of a linear epitope on the fusion glycoprotein of respiratory syncytial virus J. Gen. Virol. 71 1990 53 59
36. J.A. Melero, B. García-Barreno, I. Martínez, C.R. Pringle, and P.A. Cane Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein J. Gen. Virol. 78 1997 2411 2418
37. O. García, M. Martín, J. Dopazo, J. Arbiza, S. Frabasile, and J. Russi Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein J. Virol. 68 1994 5448 5459
38. I. Martínez, O. Valdés, A. Delfraro, J. Arbiza, J. Russi, and J.A. Melero Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification J. Gen. Virol. 80 1999 125 130
39. H. Golding, M. Zaitseva, E. de Rosny, L.R. King, J. Manischewitz, and I. Sidorov Dissection of human immunodeficiency virus type I entry with neutralizing antibodies to gp41 fusion intermediates J. Virol. 76 2002 6780 6790
40. R. García-Beato, I. Martínez, C. Francí, F.X. Real, B. García-Barreno, and J.A. Melero Host effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein Virology 221 1996 301 309